Hormone replacement therapy (HRT) has been shown to reduce many cardiovascular disease (CVD) risk factors, but many women have stopped using HRT due to reports from the Women?s Health Initiative that HRT may increase the risk of breast cancer and heart disease.
A new study, published in the Online Open Access journal Breast Cancer Research, reveals two distinct patterns in the recent breast cancer rates in U.S. women: a downturn in the incidence rates in almost all age groups above 45 years beginning in 1998/1999, consistent with a levelling off of mammography utilization, and a sharp fall in the rates between 2002 and 2003 in the age groups 50-69 years, likely reflecting the early benefit of the reduced use of HRT.
Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according to a study published in the Lancet.
A report of data from the National Cancer Institute?s Surveillance Epidemiology and End Results (SEER) database published in the New England Journal of Medicine, suggests that a decline in breast cancer incidence may be caused by a drop in hormone therapy use during the same time period.
Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according to a study published in the Lancet.
The sharp decline in the rate of new breast cancer cases in 2003 may be related to a national decline in the use of hormone replacement therapy (HRT), according to a new report in the April 19, 2007, issue of the New England Journal of Medicine.
An extended analysis of cancer rates reinforces a strong association between use of hormone replacement therapy and increased breast cancer incidence, according to research led by scientists at the University of Texas M. D. Anderson Cancer Center and published in the April 19 issue of the New England Journal of Medicine.
A new study published in the Journal of the American Medical Association found no increased risk of heart attack for women in their 50s who were taking HRT.
Men are more likely than women to benefit from the use of a clot-busting drug after stroke, according to a study published in the March 13, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
When searching for health advice online, consumers often reject Web sites with high quality medical information in favor of those with a human touch, according to new research funded by the Economic and Social Research Council.